Performance of Contrast-Enhanced Spectral Mammography to Assess Neoadjuvant Chemotherapy Response (CEDM)
Clinical trial NCT04625517 · TERMINATED
Trial details
- NCT number
- NCT04625517
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-22
- Primary completion
- 2022-06-15
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.